Creutzfeldt Jakob Disease News and Research

RSS
Creutzfeldt–Jakob disease or CJD (sometimes incorrectly referred to as mad cow disease) is a degenerative neurological disorder (brain disease) that is incurable and invariably fatal. It is the most common among the types of transmissible spongiform encephalopathy found in humans.
Possibility of wildlife-to-human crossover heightens concern about chronic wasting disease

Possibility of wildlife-to-human crossover heightens concern about chronic wasting disease

Novel learning-based framework for predicting Alzheimer’s disease progression

Novel learning-based framework for predicting Alzheimer’s disease progression

New insights into the interplay between prions and TDP-43 in neurodegenerative pathology

New insights into the interplay between prions and TDP-43 in neurodegenerative pathology

Brain changes can be studied in very early stages of neurodegenerative diseases

Brain changes can be studied in very early stages of neurodegenerative diseases

Decline in specific protein levels linked to Alzheimer’s disease, not buildup of amyloid plaques

Decline in specific protein levels linked to Alzheimer’s disease, not buildup of amyloid plaques

NPDPSC at Case Western Reserve University to receive CDC funding for better understanding of prion diseases

NPDPSC at Case Western Reserve University to receive CDC funding for better understanding of prion diseases

Researchers uncover the structure of protein fibrils linked to hereditary form of human prion disease

Researchers uncover the structure of protein fibrils linked to hereditary form of human prion disease

Prion imaging could lead to better understanding of what causes fatal neurological disorders

Prion imaging could lead to better understanding of what causes fatal neurological disorders

New technologies for early clinical diagnosis of human prion diseases

New technologies for early clinical diagnosis of human prion diseases

New study shines light on how brain cells die in prion diseases

New study shines light on how brain cells die in prion diseases

Research may provide clues to how viral infections contribute to neurodegeneration

Research may provide clues to how viral infections contribute to neurodegeneration

Human cerebral organoid model to screen drugs for treatment of Creutzfeldt-Jakob disease

Human cerebral organoid model to screen drugs for treatment of Creutzfeldt-Jakob disease

Study provides new information about the structure of prion proteins

Study provides new information about the structure of prion proteins

Study finds locations of early prion protein accumulation in the eye

Study finds locations of early prion protein accumulation in the eye

Fatal chain reaction in Alzheimer's disease starts much earlier than commonly assumed

Fatal chain reaction in Alzheimer's disease starts much earlier than commonly assumed

Trend analysis in Japan reveals Creutzfeldt-Jakob disease may not be so rare anymore

Trend analysis in Japan reveals Creutzfeldt-Jakob disease may not be so rare anymore

Researchers identify a protein that facilitates spread of SARS-CoV-2 virus through cells

Researchers identify a protein that facilitates spread of SARS-CoV-2 virus through cells

Researchers design new model to predict life expectancy of patients with Creutzfeldt‐Jakob disease

Researchers design new model to predict life expectancy of patients with Creutzfeldt‐Jakob disease

New breakthrough may help cure prion disease

New breakthrough may help cure prion disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.